Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.8300 (-4.01%) ($3.8300 - $3.8300) on Thu. Jan. 13, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.69% (three month average) | RSI | 34 | Latest Price | $3.8300(-4.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.5% a day on average for past five trading days. | Weekly Trend | CGEN declines -2.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(85%) ARKK(82%) ARKG(81%) IBUY(80%) IWO(80%) | Factors Impacting CGEN price | CGEN will decline at least -2.345% in a week (0% probabilities). VIXM(-71%) VXX(-52%) UUP(-21%) UNG(-13%) TLT(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.345% (StdDev 4.69%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.49(-217.23%) | Resistance Level | $4.28 | 5 Day Moving Average | $4.09(-6.36%) | 10 Day Moving Average | $4.2(-8.81%) | 20 Day Moving Average | $4.28(-10.51%) | To recent high | -46.5% | To recent low | 0% | Market Cap | $317m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |